SEC Form 4 · accession 0001017491-18-000083
SEELOS THERAPEUTICS, INC. · SEEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Dorsey
Other
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001017491
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 30, 2018 | M | 81,775 | — | A | 159,116 | D | |
| Common StockF2 | Aug 30, 2018 | F | 43,225 | $0.33 | D | 115,891 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units accelerated upon the Reporting Person's involuntary termination. Restricted stock units convert into common stock on a one-for-one basis.
- F2Represents shares forfeited by Reporting Person to cover certain tax liabilities incident to the vesting of the security.